作者：
Claudia,Arndt [1]
;
Anja,Feldmann [1]
;
Stefanie,Koristka [1]
;
Martin,Schäfer [2]
;
Ralf,Bergmann [1]
;
Nicola,Mitwasi [1]
;
Nicole,Berndt [1]
;
Dominik,Bachmann [3]
;
Alexandra,Kegler [1]
;
Marc,Schmitz [4]
;
Edinson,Puentes-Cala [5]
;
Javier Andrés,Soto [6]
;
Gerhard,Ehninger [7]
;
Jens,Pietzsch [1]
;
Christos,Liolios [8]
;
Gerd,Wunderlich [2]
;
Jörg,Kotzerke [9]
;
Klaus,Kopka [1]
;
Michael,Bachmann [9]
作者单位：
Department of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
[1]
Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[2]
UniversityCancerCenter (UCC), Tumor Immunology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
[3]
Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
[4]
Corporación para la Investigación de la Corrosión (CIC), Piedecuesta, Colombia.
[5]
Universidad de Santander, Cúcuta, Colombia.
[6]
GEMoaB Monoclonals GmbH, Dresden, Germany.
[7]
Department of Chemistry and Food Chemistry, School of Science, TU Dresden, Dresden, Germany.
[8]
Department of Nuclear Medicine, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
[9]
National Center for Tumor Diseases (NCT), partner site Dresden, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
[10]
German Cancer Consortium (DKTK), Heidelberg, Germany.
[11]
German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
[12]
DOI
10.1080/2162402X.2019.1659095
PMID
31646084
发布时间
2021-01-12
换一批
换一批
